ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin

The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance

(2018) Meng-Shih Weng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Physiological role of reactive oxygen species as promoters of natural defenses

(2017) Jérôme Roy et al.   FASEB JOURNAL

Reactive oxygen species and cancer paradox: To promote or to suppress?

(2017) Sehamuddin Galadari et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma

(2017) Yuting Li et al.   Cell Death & Disease

Furanodienone induces G0/G1 arrest and causes apoptosis via the ROS/MAPKs-mediated caspase-dependent pathway in human colorectal cancer cells: a study in vitro and in vivo

(2017) Ying Jiang et al.   Cell Death & Disease

Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

(2016) Peng Zou et al.   CANCER LETTERS

Chaetocin inhibits IBMX-induced melanogenesis in B16F10 mouse melanoma cells through activation of ERK

(2016) Jung-Soo Bae et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Thioredoxin reductase inhibitors: a patent review

(2016) Baoxin Zhang et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Gastric cancer

(2016) Eric Van Cutsem et al.   LANCET

The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression

(2016) Marco Tafani et al.   Oxidative Medicine and Cellular Longevity

Knockout of Mitochondrial Thioredoxin Reductase Stabilizes Prolyl Hydroxylase 2 and Inhibits Tumor Growth and Tumor-Derived Angiogenesis

(2015) Juliane Hellfritsch et al.   ANTIOXIDANTS & REDOX SIGNALING

Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells

(2015) Xianfang Liu et al.   APOPTOSIS

Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells

(2015) Xu Li et al.   CANCER LETTERS

The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells

(2015) Y-S Lai et al.   Blood Cancer Journal

Cellular mechanisms and physiological consequences of redox-dependent signalling

(2014) Kira M. Holmström et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism

(2014) D Dixit et al.   Cell Death & Disease

Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance

(2014) L Truitt et al.   Oncogenesis

Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases

(2013) Fanny L Cherblanc et al.   Nature Chemical Biology

Targeted therapies in gastric cancer—the dawn of a new era

(2013) Manish A. Shah   Nature Reviews Clinical Oncology

Principles in Redox Signaling: From Chemistry to Functional Significance

(2012) Alberto Bindoli et al.   ANTIOXIDANTS & REDOX SIGNALING

Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence

(2012) Jae Yun Lim   WORLD JOURNAL OF GASTROENTEROLOGY

The anticancer effects of chaetocin are independent of programmed cell death and hypoxia and are associated with inhibition of endothelial cell proliferation

(2011) C R Isham et al.   BRITISH JOURNAL OF CANCER

Akt signalling in health and disease

(2011) Ingeborg Hers et al.   CELLULAR SIGNALLING

Small molecule inhibitors of mammalian thioredoxin reductase

(2011) Wenqing Cai et al.   FREE RADICAL BIOLOGY AND MEDICINE

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1

(2011) H Chaib et al.   LEUKEMIA

Oxidative stress, inflammation, and cancer: How are they linked?

(2010) Simone Reuter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1α pre-mRNA in mice and in vitro

(2010) Yoon-Mi Lee et al.   HEPATOLOGY

Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase

(2009) Valentina Gandin et al.   BIOCHEMICAL PHARMACOLOGY

ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells

(2009) Ji Cao et al.   FREE RADICAL BIOLOGY AND MEDICINE

Terpyridine–platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1

(2009) Yan-Chung Lo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Targeting the phosphoinositide 3-kinase pathway in cancer

(2009) Pixu Liu et al.   NATURE REVIEWS DRUG DISCOVERY

The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase

(2008) Jennifer D. Tibodeau et al.   ANTIOXIDANTS & REDOX SIGNALING

Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer

(2007) Terumasa Noike et al.   HUMAN PATHOLOGY